Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PBLS compared with TYRA: revenue, margins and what each company keeps, and the suppliers and customers both name
PBLS
Parabilis Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
TYRA
Tyra Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PBLS
Parabilis Medicines, Inc.
vs
TYRA
Tyra Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PBLS, solid
TYRA, dashed
PBLS
Parabilis Medicines, Inc.
Change
27.91
▼
−2.77%
· post 28.32
Mkt cap
$818.7M
Revenue
$148,000
Q2 FY26
TYRA
Tyra Biosciences, Inc.
Change
21.08
▼
−1.86%
· post 21.08
Closed
Oct 30 '26
Mkt cap
$1.3B
Revenue
—
vs
Compare
Closed
Oct 30 '26
PBLS
Parabilis Medicines, Inc.
vs
TYRA
Tyra Biosciences, Inc.
27.91
▼
−2.77%
post 28.32
Price
21.08
▼
−1.86%
post 21.08
$818.7M
Mkt cap
$1.3B
Q2 FY26
$148,000
Revenue
—
Change
Change
PBLS
27.91
▼
−2.77%
vs
TYRA
21.08
▼
−1.86%
Closed
Oct 30 '26